Author Topic: GUD.V - Knight Therapeutics  (Read 32465 times)

Drokos

  • Newbie
  • *
  • Posts: 38
Re: GUD.V - Knight Therapeutics
« Reply #10 on: July 30, 2014, 08:02:49 PM »
My post simply said they are likely to sell their voucher for less than $100m and I provided the recent comp as support. It said nothing about doubting Mr. Goodman.

I have actually said in the thread that I believe in him, despite the health issues and risks, but that I thought the stock price was too high given that the expectations for the voucher are too high. We'll see how it trades tomorrow. I do think he can compound capital at a very attractive rate, so I would be pleased to buy a big position if this trades for anything near book value(assuming a voucher sale of somewhere around $40m).



treehugger

  • Newbie
  • *
  • Posts: 12
Re: GUD.V - Knight Therapeutics
« Reply #11 on: July 31, 2014, 07:10:30 PM »
My post simply said they are likely to sell their voucher for less than $100m and I provided the recent comp as support. It said nothing about doubting Mr. Goodman.

I have actually said in the thread that I believe in him, despite the health issues and risks, but that I thought the stock price was too high given that the expectations for the voucher are too high. We'll see how it trades tomorrow. I do think he can compound capital at a very attractive rate, so I would be pleased to buy a big position if this trades for anything near book value(assuming a voucher sale of somewhere around $40m).

Hmm.. shouldn't the voucher be now worth MORE than the amount sold by Biomarin (67.5 million rather than the 40 million)?  I'm thinking more due to scarcity value. After all, if you wanted the voucher you only have one guy to talk to now..

Only 4 in existence - Novartis -used, Janssen - use for itself?, Biomarin - sold, Knight - status unknown..

snowball82

  • Sr. Member
  • ****
  • Posts: 334
Re: GUD.V - Knight Therapeutics
« Reply #12 on: July 31, 2014, 08:02:34 PM »

[/quote]

Hmm.. shouldn't the voucher be now worth MORE than the amount sold by Biomarin (67.5 million rather than the 40 million)?  I'm thinking more due to scarcity value. After all, if you wanted the voucher you only have one guy to talk to now..

Only 4 in existence - Novartis -used, Janssen - use for itself?, Biomarin - sold, Knight - status unknown..
[/quote]

And the guy can negociate a deal, we know that ! This voucher has probably a tremendous value for Big pharma.


snowball82

  • Sr. Member
  • ****
  • Posts: 334
Re: GUD.V - Knight Therapeutics
« Reply #14 on: August 13, 2014, 04:58:04 AM »
Probably a strategic step to monetize.

snowball82

  • Sr. Member
  • ****
  • Posts: 334
Re: GUD.V - Knight Therapeutics
« Reply #15 on: August 13, 2014, 06:08:55 PM »
Competition can begin. Knight to auction FDA priority-review voucher. What is the value of this voucher for a big pharma company  ?

http://www.theglobeandmail.com/report-on-business/knight-to-auction-fda-priority-review-voucher/article20022459/
« Last Edit: August 13, 2014, 06:25:36 PM by snowball82 »

treehugger

  • Newbie
  • *
  • Posts: 12
Re: GUD.V - Knight Therapeutics
« Reply #16 on: August 13, 2014, 09:43:38 PM »
Competition can begin. Knight to auction FDA priority-review voucher. What is the value of this voucher for a big pharma company  ?

It probably makes more sense to trade it Big Pharma for cash and under promoted licensing rather than just straight cash.

snowball82

  • Sr. Member
  • ****
  • Posts: 334
Re: GUD.V - Knight Therapeutics
« Reply #17 on: August 14, 2014, 04:14:10 AM »
They will take the best offer ! Maybe more on the confrence call at 8:30

LesPaul

  • Jr. Member
  • **
  • Posts: 95
Re: GUD.V - Knight Therapeutics
« Reply #18 on: August 14, 2014, 11:33:15 AM »
Initiated a small position today. Don't know whether they'll get 60m or 100+m for the waiver but I'm more interested to see what they do with that cash afterwards.


gary17

  • Hero Member
  • *****
  • Posts: 1189